Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid ...

Aurora Cannabis Inc (ACB) reports a 29% increase in net revenue, driven by a 93% surge in international medical cannabis ...

Net income: CA$2.60m (up 40% from 2Q 2024). Profit margin: 3.2% (up from 2.9% in 2Q 2024). EPS: CA$0.05 (up from CA$0.048 in ...

Shares of Canada-based Aurora Cannabis Inc. ($ACB) jumped more than 2% on Tuesday, ahead of the cannabis producer’s ...

Canadian medical marijuana giant Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) reported its financial results Wednesday for the ...

Aurora Cannabis (US) ( (ACB) ) has released its Q2 earnings. Here is a breakdown of the information Aurora Cannabis (US) presented to its ...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced its financial results for the fiscal 2025 second quarter. Total revenue rose year-over-year and the company has a positive outlook for the ...

Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter.

Aurora Cannabis (TSE:ACB) has released an update. Aurora Cannabis reported impressive fiscal 2025 second-quarter results, achieving a record ...

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical ...

CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...